With 15 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $20.09B. The average expense ratio is 0.72%. Biotech ETFs can be found in the following asset classes:
The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $10.00B in assets. In the last trailing year, the best performing Biotech ETF was the BBC at 50.64%. The most-recent ETF launched in the Biotech space was the ETFMG Treatments Testing and Advancements ETF GERM in 06/17/20.